title: Effect of combination therapy between thyme oil and ciprofloxacin on ulcer-forming Shigella flexneri.
abstract: BACKGROUND
  Shigella flexneri is a Gram-negative bacteria that has the ability to invade the epithelium of the colon and cause colon ulcers.
  
  
  METHODS
  The ability of isolated Shigella flexneri from bloody diarrhea to cause colon ulcers was investigated by histopathological examination via oral administration of the bacteria to adult male albino Sprague-Dawley rats. The antibacterial activity of thyme oil, ciprofloxacin, and their combination were evaluated in vitro and in vivo.
  
  
  RESULTS
  Oral administration of 12×108 CFU/mL of S. flexneri was able to cause colon ulcers. Thyme oil had the highest antibacterial activity among other investigated oils (minimum inhibitory concentration [MIC] 150µL/L). Ciprofloxacin had the highest antimicrobial activity against S. flexneri (MIC 0.4mg/L). The synergism between thyme oil and ciprofloxacin showed the maximum growth inhibition of S. flexneri. The synergistic activity of thyme oil and ciprofloxacin succeeded in healing the epithelial surface of the colon and decreased the inflammation of the lamina propria; it also decreased the bacterial load in the infected colon, while the commercial drug failed to heal the colon ulcer. Thyme oil, ciprofloxacin, and their combination showed different degrees of effects on the bacterial cell structure by transmission and scanning electron microscopes.
  
  
  CONCLUSIONS
  The combination of thyme oil and ciprofloxacin gave synergistic activity, which proved to be more effective in inhibiting the growth of ulcer-forming S. flexneri, healing the colon ulcer, and decreasing infiltration of the lamina propria with inflammatory cells.
authors.affiliation: Faculty of Science, Tanta University, Tanta, Egypt. ngamal1973@yahoo.com.
authors.forename: Nanis Gamal
authors.initials: NG
authors.lastname: Allam
authors.forename: Ezzat Abd El-Aziz
authors.initials: EA
authors.lastname: Eldrieny
authors.forename: Amira Zaky
authors.initials: AZ
authors.lastname: Mohamed
mesh_terms: D000818:Animals; D000900:Anti-Bacterial Agents / Q000008:administration & dosage* / Q000494:pharmacology; D058491:Bacterial Load; D002939:Ciprofloxacin / Q000008:administration & dosage* / Q000494:pharmacology; D003093:Colitis, Ulcerative / Q000188:drug therapy* / Q000382:microbiology / Q000473:pathology; D003106:Colon / Q000382:microbiology / Q000473:pathology; D004357:Drug Synergism; D004359:Drug Therapy, Combination; D004405:Dysentery, Bacillary / Q000150:complications / Q000188:drug therapy*; D008297:Male; D008826:Microbial Sensitivity Tests; D009822:Oils, Volatile / Q000008:administration & dosage* / Q000494:pharmacology; D011446:Prospective Studies; D017207:Rats, Sprague-Dawley; D012763:Shigella flexneri / Q000187:drug effects* / Q000302:isolation & purification; D013950:Thymus Gland / Q000737:chemistry*; D016896:Treatment Outcome
chemical_list: D000900:Anti-Bacterial Agents; D009822:Oils, Volatile; D002939:Ciprofloxacin